Sunday, October 20, 2019

Sunday, October 20, 2019

Latest News

FDA unveils guidances for digital health care

The U.S. Food and Drug Administration (FDA) recently unveiled a series of guidances about utilizing digital health tools to help patients.

Pressure mounts on politicians, FDA to react to vaping-related illnesses, deaths

According to an article on the Forbes website, vaping will impact two sectors of the financial markets the most: Big Tobacco and marijuana stocks.

FDA to unveil new warning labels for cigarettes

The U.S. Food and Drug Administration is planning on unveiling a new rule where they will implement new health warnings in regard to cigarette packages.

Republicans look to Fair Care Act of 2019 to improve health insurance system

Some in Congress are hoping the Republican sponsored Fair Care Act of 2019 will open the floodgates for Americans to buy health insurance.

Republican senators introduce innovation-driven drug-treatment bill; brace for resistance from FDA

Two Republican senators recently introduced a bill they claim would combat U.S. drug shortages and drive down the prices of drugs and medical devices by allowing patients to select treatments approved in other countries.

FDA expanding its drug approval process by incorporating ‘real world’ data and evidence

The U.S. Food and Drug Administration is using some new tools in its drug approval process and at least one prominent industry leader is giving the government entity a thumb’s up.

AVA president says parents should play of a role in banning sales of vape products to minors

The American Vaping Association says FDA fear-mongering on vaping products for minors could end up making the products more enticing.

Doctor says FDA should do more to combat opioid crisis

The Food and Drug Administration unveiled yet another draft guidance on opioid addiction, but one doctor remains unimpressed.

Doctors, not FDA, should be empowered to deal with opioid crisis, association says

The Food and Drug Administration recently unveiled a new draft guidance for tackling opioid addiction, and scheduled a public hearing for Sept. 17 to discuss the crisis.

Cannabis regulation not in FDA jurisdiction, industry expert says

The Food and Drug Administration has been gathering comments on how to regulate cannabis products, but a cannabis industry expert says FDA should lay off and let states do their jobs.

Should FDA be allowed to share in the profits during its approval process?

A Hawaii doctor opined in a column if the Food and Drug Administration should share in pharmaceutical and medical research profit.

Are price controls the answer when it comes to gene therapy drugs?

Some believe with the advent of gene therapy, the future of medicine has been seen.

Right to Try legislation sits in North Carolina senate committee

North Carolina House Bill 934, which passed unanimously 114-0, was sent to the State Senate where it currently is in committee.

FDA to shut down secret recording program

When the FDA made the announcement, it said it would open past records within weeks. So why did the FDA have such a policy and why was it secret?

Bipartisan prescription drug price bill draws criticism from industry expert

How much is too much when it comes to the price of prescription drugs? This week, U.S. Senators John Cornyn (R-Texas) and Richard Blumenthal (D-Connecticut) crossed party lines and introduced a bill to answer that very question.

Doctor says stem cell providers not immune from legal action under proposed North Carolina law

North Carolina passed a Right to Try law back in 2015 yet a bill introduced in April could expand that stem cell treatment law.

Doctors disagree on FDA approach toward stem cell treatments

WASHINGTON -- The New York Times recently published a lengthy story about stem cell treatments, describing the Food and Drug Administration’s approach as industry friendly.

Arizona doctor disagrees with FDA papers that claim agency should be indepedent

Seven former Food and Drug Administration commissioners suggested in a couple of articles that the FDA should become an independent agency

Health policy expert rejects suggestion of FDA independence

Two papers written by seven former FDA commissioners suggest the organization should become an independent agency.

CCHF president speaks out on FDA drug approval process

Citizensʼ Council for Health Freedom Media president Twila Brase says the current FDA drug approval process is too long and expensive.

FDA Reporter